|
DOPEY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.610000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.830000E-01 |
| Normal-vs-Stage2 |
6.057600E-01 |
| Normal-vs-Stage3 |
2.942200E-02 |
| Normal-vs-Stage4 |
3.383900E-03 |
| Stage1-vs-Stage2 |
9.524400E-01 |
| Stage1-vs-Stage3 |
1.210970E-01 |
| Stage1-vs-Stage4 |
1.591740E-02 |
| Stage2-vs-Stage3 |
4.397200E-01 |
| Stage2-vs-Stage4 |
1.658610E-01 |
| Stage3-vs-Stage4 |
2.926800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.446100E-02 |
| Normal-vs-AfricanAmerican |
4.107000E-01 |
| Normal-vs-Asian |
7.785800E-01 |
| Caucasian-vs-AfricanAmerican |
6.979400E-01 |
| Caucasian-vs-Asian |
4.618200E-01 |
| AfricanAmerican-vs-Asian |
5.843800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.040000E-02 |
| Normal-vs-Female |
5.535200E-01 |
| Male-vs-Female |
5.834000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.442400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.444600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.702250E-02 |
| Normal-vs-Age(81-100Yrs) |
2.942000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.148960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.201200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.381400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.322200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.853600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.341600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.940400E-02 |
| Normal-vs-Grade 2 |
8.548600E-01 |
| Normal-vs-Grade 3 |
1.652450E-02 |
| Normal-vs-Grade 4 |
1.60424999999798E-05 |
| Grade 1-vs-Grade 2 |
2.060000E-02 |
| Grade 1-vs-Grade 3 |
2.011500E-04 |
| Grade 1-vs-Grade 4 |
2.4618999999948E-05 |
| Grade 2-vs-Grade 3 |
2.215900E-03 |
| Grade 2-vs-Grade 4 |
7.15430000020056E-07 |
| Grade 3-vs-Grade 4 |
1.117910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.031200E-01 |
| Normal-vs-ccB subtype |
8.755600E-04 |
| ccA subtype-vs-ccB subtype |
3.40470000004256E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.537800E-01 |
| Normal-vs-N1 |
1.024050E-02 |
| N0-vs-N1 |
9.916400E-02 |
|
|
